Research analysts covering Medirom Healthcare Technologies.
Recent press releases and 8-K filings for MRM.
Medirom Healthcare Technologies Inc. Enters Loan and Convertible Bond Agreements with Kufu
MRM
Debt Issuance
Convertible Preferred Issuance
- Medirom Healthcare Technologies Inc. (Medirom) acknowledged a JPY 200,000,000 loan from Kufu Company Holdings Inc. (Kufu) as of December 31, 2025, with an annual interest rate of 10%, and an amended repayment due date of March 31, 2026.
- To secure this loan, Medirom created a pledge over 48,219 shares of its subsidiary, MEDIROM MOTHER Labs Inc., in favor of Kufu.
- On December 31, 2025, Medirom issued JPY 275,000,000 in 4th Unsecured Convertible-Type Corporate Bonds with Share Options to Kufu, which refinanced an equivalent amount of principal from previously matured 1st Bonds.
- The 4th Convertible Bonds carry a 5.0% annual interest rate, mature on June 30, 2026 (extendable to December 25, 2026), and have a conversion price of JPY 330 per common share.
3 days ago
MEDIROM Healthcare Technologies Inc. to deploy World ID Orbs across 3,000 locations
MRM
New Projects/Investments
Product Launch
Partnership
- MEDIROM Healthcare Technologies Inc. has entered into a Master Service Agreement with Tools for Humanity and the World Foundation to accelerate the adoption of World ID in Japan.
- This initiative involves deploying Orb authentication devices across approximately 3,000 locations nationwide, a significant scale-up from the initially planned 100 locations.
- The deployment strategy includes expanding within the Re.Ra.Ku Group to approximately 300 wellness centers and collaborating with a Management Partner Network to reach the 3,000-location target, with 370 third-party locations currently in negotiations.
Jan 23, 2026, 9:30 PM
Medirom Healthcare Technologies Inc. Partners with World on "Proof of Human" Deployment in Japan
MRM
New Projects/Investments
Product Launch
Revenue Acceleration/Inflection
- On December 29, 2025, MEDIROM Healthcare Technologies Inc. (MRM) announced a Master Service Agreement with Tools For Humanity and the World Foundation to deploy the Proof of Human network in Japan.
- Under the agreement, MEDIROM will be responsible for the construction and operation of the Proof of Human network, a project co-created by Sam Altman and Alex Blania, and will establish a dedicated "MEDIROM World Proof of Human Task Force" for its nationwide rollout.
- This initiative is anticipated to contribute to MEDIROM's revenue through operation fees and related services, utilizing the company's approximately 300 physical locations across Japan for rapid deployment.
Dec 29, 2025, 12:45 PM
MEDIROM Healthcare Technologies Inc. announces issuance of convertible corporate bonds
MRM
Debt Issuance
- MEDIROM Healthcare Technologies Inc. issued JPY 400,000,000 in Third Unsecured Convertible-Type Corporate Bonds with Share Options, with the sale expected to close on December 12, 2025.
- These bonds accrue interest at a rate of 2.0% per annum and have a maturity date of June 30, 2026, which the company may extend to December 25, 2026.
- Bondholders can convert each bond into common shares at a conversion price of JPY 343 per common share between December 12, 2025, and June 10, 2026 (or December 7, 2026, if the maturity date is extended).
- The company intends to use the JPY 400,000,000 gross proceeds from the sale for general corporate or financing purposes.
Dec 12, 2025, 12:40 AM
Medirom Subsidiary Partners with TD SYNNEX to Accelerate Product Adoption
MRM
Product Launch
New Projects/Investments
Revenue Acceleration/Inflection
- MEDIROM Healthcare Technologies Inc. announced on December 4, 2025, that its subsidiary, MEDIROM MOTHER Labs Inc., has entered into a distributor agreement with TD SYNNEX K.K..
- This partnership aims to accelerate the national adoption of the MOTHER Bracelet, a recharge-free smart tracker, and REMONY, a remote health monitoring system.
- TD SYNNEX will utilize its nationwide sales network and IT product distribution expertise to expand the market presence of these health-tech solutions.
- The MOTHER Bracelet is highlighted as the world's first 24/7 recharge-free smart tracker, capable of recording five fundamental health metrics.
Dec 4, 2025, 9:30 PM
MEDIROM MOTHER Labs Secures Internal Capital Investment
MRM
New Projects/Investments
Product Launch
- MEDIROM Healthcare Technologies Inc.'s subsidiary, MEDIROM MOTHER Labs Inc., completed a private placement of new shares to internal investors on October 30, 2025.
- The investment was made by its President and CEO, Yoshio Uekusa, and Director, Ryo Saito.
- This transaction is part of a previously announced Series A equity financing round valued at ¥9 billion.
- The capital increase aims to strengthen the capital base and accelerate the development of upgraded "MOTHER Bracelet" wearable devices and the establishment of systems for launching new products into the market.
Oct 30, 2025, 8:10 PM
Medirom Healthcare Technologies Adopts Cryptocurrency for Treasury Strategy
MRM
New Projects/Investments
- MEDIROM Healthcare Technologies Inc. (MRM) has approved a new treasury strategy to incorporate cryptocurrency, resolving to hold Worldcoin (WLD) as a primary reserve asset and Ethereum (ETH) as a secondary asset, effective October 29, 2025.
- As of October 28, 2025, the company holds 6,840 WLD.
- The WLD will be utilized to incentivize users of the MOTHER Bracelet for large-scale vital data collection, with the strategy aiming to diversify assets, mitigate financial risks, and explore new business growth opportunities.
Oct 29, 2025, 1:34 PM
Medirom Healthcare Technologies Inc. Reports Financial Results for Six Months Ended June 30, 2025
MRM
Earnings
Demand Weakening
Profit Warning
- Medirom Healthcare Technologies Inc. reported a 6.7% decrease in total revenue to JPY3,243,371 thousand (US$22,497 thousand) and an 18.6% increase in net loss to JPY(690,471) thousand (US$(4,789) thousand) for the six months ended June 30, 2025, compared to the same period in 2024.
- The company's management concluded that substantial doubt exists about its ability to continue as a going concern due to a working capital deficit, accumulated deficit, net loss, and negative cash flows from operations, with cash and cash equivalents of JPY32,663 thousand (US$227 thousand) as of June 30, 2025, potentially insufficient for the next 12 months.
- Net cash used in operating activities improved significantly, decreasing to JPY(351,912) thousand (US$(2,441) thousand) for the six months ended June 30, 2025, from JPY(785,720) thousand (US$(5,450) thousand) in the prior year period.
- The core Relaxation Salon Segment's revenue decreased by 7.5% to JPY2,902,972 thousand (US$20,136 thousand) for the six months ended June 30, 2025, while the Digital Preventative Healthcare Segment's revenue grew by 64.7% to JPY71,954 thousand (US$499 thousand).
Oct 21, 2025, 9:24 PM
MEDIROM Healthcare Technologies Subsidiary Completes Series A Funding
MRM
New Projects/Investments
- On October 9, 2025, MEDIROM Healthcare Technologies Inc. announced that its subsidiary, MEDIROM MOTHER Labs Inc., approved a Series A equity financing round.
- The Series A round valued MEDIROM MOTHER Labs Inc. at JPY9 billion.
- The financing involves a private placement of new shares to two officers of MOTHER Labs, Yoshio Uekusa and Ryo Saito, with funding scheduled to occur by the end of October.
- The capital increase aims to strengthen the subsidiary's capital base, accelerate the development of an upgraded MOTHER Bracelet, and establish systems for bringing products to market.
Oct 9, 2025, 10:10 AM
MEDIROM Healthcare Technologies Inc. Announces August 2025 Key Performance Indicators
MRM
- MEDIROM Healthcare Technologies Inc. (MRM) announced its Key Performance Indicators (KPIs) for August 2025, reporting 82,780 total customers served and JPY 7,530 sales per customer in its salon operation business.
- The salon operation business achieved a customer repeat ratio of 76.5% and an operation ratio of 48.4% in August 2025, representing a year-over-year increase from 47.3%.
- As of August 2025, the company operated 299 salons.
- In its Health Tech Business, the cumulative number of contracts with corporate insurance associations reached 101, and the Lav® app had a cumulative total of 10,951 users.
Sep 24, 2025, 10:10 AM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more